Hikma Pharmaceuticals PLC (HIK)
Industry Drug Manufacturers - Specialty & Generic
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
1,826.00p
Buy
1,827.00p
-11.00p (-0.60%)
Prices updated at 12 Nov 2024, 16:39 GMT
| Prices minimum 15 mins delay
Prices in GBX
Hikma Pharmaceuticals PLC develops, manufactures and markets a broad range of branded and non-branded generic pharmaceutical products across the US, the MENA region, and Europe.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
|---|---|
| 2023 | 48.35 |
| 2022 | 49.19 |
| 2021 | 50.96 |
| 2020 | 51.30 |
| 2019 | 49.30 |
| 2018 | 50.72 |
| 2017 | 49.95 |
| 2016 | 50.56 |
| 2015 | 56.81 |
Valuation data table
Year | Price / Sales |
|---|---|
| 2024 | 1.84 |
| 2023 | 1.85 |
| 2022 | 1.69 |
| 2021 | 2.87 |
| 2020 | 3.64 |
| 2019 | 2.96 |
| 2018 | 2.58 |
| 2017 | 1.87 |
| 2016 | 3.10 |
| 2015 | 4.67 |
| 2014 | 4.18 |
Price/Forward earnings (YTD)
11.85
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
|---|---|
| 2023 | 4.15 |
| 2022 | 4.25 |
| 2021 | 9.90 |
| 2020 | 10.69 |
| 2019 | 13.09 |
| 2018 | 8.19 |
| 2017 | -21.75 |
| 2016 | 4.45 |
| 2015 | 10.40 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2023 | 2.13 |
| 2022 | 2.09 |
| 2021 | 1.78 |
| 2020 | 1.94 |
| 2019 | 1.86 |
| 2018 | 2.08 |
| 2017 | 2.24 |
| 2016 | 1.82 |
| 2015 | 1.94 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
